Download Echoes of Incas mp3

Artist: Echoes of Incas: mp3 download    Genre(s):  Ethnic Other     Discography:      Ventana al Sol    Year: 1995    Tracks: 11      The Inca Empire    Year:     Tracks: 13 Echoes of Incas was formed partly from the same members as the grouping Ah-Kin. The mathematical group uses traditional Andean instruments, such as the pan pipes, drums, rattles, and guitars; electric guitar and freshwater bass ar added for a vibrant pan-cultural sound. Members of Echoes of Incas, which differ on each album, hail from many countries: Arturo Garcia Orozco (the paint composer, from Mexico), Konrad Rhee (U.S.A.), Roberto E. Duenas (El Salvador), Gilberto Reyes (Republic of Peru), Luis Felipe Gonzales (Republic of Venezuela), Cesar Regino (United Mexican States), Sergio A. Villegas (Chili peppercorn), Michael O'Day (Puerto Rico), Pathik Desai (U.S.A.), Gino Gambao (Republic of Peru), and Kambiz Pakandam (Persia).

Presumptive Democratic Presidential Nominee Obama Discusses Single-Payer Health Care System

div























Latest News For This Category
Commonwealth Fund Survey Shows More U.S. Residents Unable To Pay Medical Bills
21 Aug 2008

Presumptive Democratic Presidential Nominee Obama Discusses Single-Payer Health Care System
21 Aug 2008

Poll Examines Public's Issues Paying For Health Care, Views On Presidential Candidates' Health Care Plans
21 Aug 2008

View more news...

Today's Featured Health Videos









more videos are available in our health videos section.




Most Popular Categories

cancer �
cardiovascular �
dermatology �
hiv �
nutrition �

diabetes �
obesity �
pediatrics �
psychology �
neurology �
alcohol �

urology �
breast cancer �
women's health �
infectious diseases �
respiratory �
sexual health �

gastrointestinal �
pain �
pregnancy �
bones �
medical devices �
medicare �

depression �
prostate �
smoking �
alzheimer's �
allergy �
sleep �

biology �
genetics �
eye health �
sports medicine �
hypertension �
abortion �

health insurance �
autism �
stem cell research �
adhd �
liver disease �
multiple sclerosis �

arthritis �
pharma industry �
seniors �
dentistry �
it �
nursing �

blood �
fertility �

More info

• More women 40 to 44 remaining childless
• Poor sleep equals high BP for teens
• Body Type: Are You an Apple or a Pear?
• Calif. court says doctors can’t deny health care to gays
• Blood still carries protection against killer 1918 flu

Nutra Pharma Announces Initial Positive Safety Data From Clinical Study In Adrenomyeloneuropathy (AMN)

�Nutra Pharma Corp. (OTCBB: NPHC),
a biotechnology party that is developing drugs for HIV and Multiple
Sclerosis, has announced that its wholly-owned drug discovery
subsidiary, ReceptoPharm, has reported initial positive safety data
from its Phase IIb/IIIa clinical study of RPI-78M for treating
Adrenomyeloneuropathy (AMN). RPI-78M is ReceptoPharm's prima drug
nominee for treating neurological and autoimmune disorders.



"Initial reports and feedback from physicians involved with this
clinical study birth reported that patients birth experienced no adverse
side of meat effects from RPI-78M," explained Paul Reid, CEO of ReceptoPharm.
"This is an important index number of the success of this clinical study,
as it provides the medical and pharmacological communities with early
evidence supporting the safety of our leading drug candidate,
RPI-78M," he concluded.



Adrenomyeloneuropathy (AMN) is a rare inherited metabolic disorder
that affects approximately 30,000 people global. The disorder is
characterized by the loss of the butterball covering (medulla sheath) on
nerve fibers within the brain (cerebral demyelination) and the
progressive degeneration of the adrenal gland (adrenal atrophy).
Neurological disability in AMN is slowly progressive over several
decades.



AMN interests the wider neurologic community because of its
similarities to Multiple Sclerosis (MS). There is currently no
approved treatment for AMN. Additionally, the disease's rarity
designates it as an orphan drug prospect both in Europe and in the
U.S. The Company has applied for Orphan drug status in the U.S. and
intends on doing so for the EU.



ReceptoPharm expects to deliver the complete clinical findings and
information from this study by the end of September.

About Nutra Pharma Corp.


Nutra Pharma Corp. is a biopharmaceutical company specializing in the
acquisition, licensing and commercialization of pharmaceutical
products and technologies for the management of neurological
disorders, cancer, autoimmune and infectious diseases. Nutra Pharma
Corp. through its subsidiaries carries out basic drug discovery
research and clinical development and also seeks strategic licensing
partnerships to reduce the risks associated with the drug growing
process. The Company's subsidiary company, ReceptoPharm, Inc., is development
these technologies for the production of drugs for HIV and Multiple
Sclerosis ("MS"). The Company's subsidiary, Designer Diagnostics, is
engaged in the research and development of diagnostic test kits
intentional to be used for the speedy identification of infectious
diseases such as Tuberculosis (TB) and Mycobacterium
avium-intracellulare (MAI). Nutra Pharma continues to identify and
acquire rational property and companies in the biotech arena.

SEC Disclaimer


This press release contains forward-looking statements. The speech or
phrases "would be," "will admit," "intends to," "will likely result,"
"are expected to," "will continue," "is awaited," "estimate,"
"project," or similar expressions ar intended to identify
"modern statements." Actual results could differ materially
from those projected in Nutra Pharma's ("the Company") business plan.
The Company's business is subject to various risks, which are
discussed in the Company's filings with the Securities and Exchange
Commission ("SEC").� The initial safety data from the clinical study
in Adrenomyeloneuropathy (AMN) should not be construed as an
meter reading in any way whatever of the value of the Company or its
common fund.� The Company's filings may be accessed at the SEC's
Edgar arrangement at world Wide Web.sec.gov.� Statements made herein are as of the
date of this press release and should not be relied upon as of whatsoever
subsequent date. The Company cautions readers not to place reliance on
such statements. Unless otherwise compulsory by applicable law, we do
not undertake, and we specifically disclaim any obligation, to update
whatever forward-looking statements to reflect occurrences, developments,
unanticipated events or luck after the date of such statement.

http://www.NutraPharma.com
http://www.ReceptoPharm.com


More info

• Laser weapon to leave target clueless
• Carers speak out over standards
• Fewer than half of Nunavut’s doctors actually live there
• New Law Means More Ellies Won’t Die
• Multiple deployments raise mental health risks

Music highlights, July 28

John Fohl strums at Dos Jefes Uptown Cigar Bar. The Russell Batiste Band fills in at the Maple Leaf....

More info

• Lawsuit Spells Bad News For Facebook’s Scrabulous (But Still Gets You 38 Points)
• Carl Palmer
• Arcane Sun
• Lil Wayne Predictably Sued by Litigious Geezers
• Barry Brown

Flashbulb

   
Artist: Flashbulb

   Genre(s): 
Dance
   

---

Discography:


   
 Reunion

   Year: 2005   
Tracks: 17

---

 





Movies and music

Otis Rush

   
Artist: Otis Rush

   Genre(s): 
Blues
   Rock
   

---

Discography:


   
 Door to Door

   Year: 2007   
Tracks: 14


   
 Cold Day in Hell

   Year: 1993   
Tracks: 10


   
 Mourning in the Morning

   Year: 1992   
Tracks: 11


   
 Lost in the Blues

   Year: 1991   
Tracks: 1


   
 Professor Blues Review, Montreux, 1986

   Year: 1986   
Tracks: 9


   
 Otis Rush and Friends

   Year: 1986   
Tracks: 12


   
 I Can't Quit You Baby

   Year:    
Tracks: 16


   
 Double Trouble

   Year:    
Tracks: 13


   
 Any Place I'm Going

   Year:    
Tracks: 11

---

Breaking into the R&B Top Ten his identical number one time out in 1956 with the startlingly intense dull blues "I Can't Quit You Baby," left-hander guitar player Otis Rush subsequently established himself as 1 of the chancellor bluesmen on the Chicago circuit. He remains so today.


Hurry is often credited with beingness one of the architects of the West side guitar style, on with Magic Sam and Buddy Guy. It's a cloudy honour, since Otis Rush played clubs on Chicago's South side merely as often during the sound's late-'50s incubation menstruum. Nevertheless, his esteemed position as a meridian Chicago pioneer is eternally assured by the sonority, vibrato-enhanced guitar work that remains his stock-in-trade and a tortured, super-intense vocal delivery that tin force the hairs on the gage of your neck upwards in dumb salute.


If talent alone were the recipe for widespread achiever, Rush would presently be Chicago's ahead blues creative person. But destiny, hazard, and the guitarist's possess idiosyncrasies have conspired to hold him back on several occasions when chance was virtually mendicancy to be recognised.


Rush came to Chicago in 1948, met Muddy Waters, and knew right away what he wanted to do with the breathe of his living. The omnipresent Willie Dixon caught Rush's act and signed him to Eli Toscano's Cobra Records in 1956. The frighteningly intense "I Can't Quit You Baby" was the maid endeavour for both artist and label, streaking to number sestet on Billboard's R&B chart.


His 1956-58 Cobra bequest is a splendid one, imposing by the Dixon-produced minor key masterpieces "Two-fold Trouble" and "My Love Will Never Die," the nails-tough "Leash Times a Fool" and "Keep on Loving Me Baby," and the rhumba-rocking classical "All Your Love (I Miss Loving)." Rush ostensibly dotted off the latter tune in the motorcar en route to Cobra's West Roosevelt Road studios, where he would cut it with the nucleus of Ike Turner's jazz band.


Later Cobra closed up shop, Rush's recording fortunes mostly floundered. He followed Dixon all over to Chess in 1960, newspaper clipping some other graeco-Roman (the stunning "So Many Roads, So Many Trains") earlier moving on to Duke (one sole exclusive, 1962's "Prep"), Vanguard, and Cotillion (there he cut the underrated Mike Bloomfield-Nick Gravenites-produced 1969 album Bereavement in the Morning, with yeoman help from the house calendar method of birth control division in Muscle Shoals).


Distinctive of Rush's fearful hazard was the unnerving saga of his Proper Place, Wrong Time album. Laid down in 1971 for Capitol Records, the goliath label inexplicably took a top on the externalize despite its obvious excellence. It took another five years for the put to emerge on the diminutive Bullfrog label, blunting Rush's momentum once once again (the album is now useable on HighTone).


An spotty only worthwhile 1975 put for Delmark, Cold Day in Hell, and a host of self-colored live albums that more often than not sound very similar kept Rush's gilt-edged name in the market place to some extent during the seventies and '80s, a distressing period for the legendary southpaw.


In 1986, he walked out on an expensive sitting for Rooster Blues (Louis Myers, Lucky Peterson, and Casey Jones were among the assembled sidemen), complaining that his amplifier didn't sound right and thereby scuttling the entire fancy. Alligator picked up the rights to an album he had through overseas for Sonet primitively called Troubles, Troubles. It turned out to be a prophetical claim: much to Rush's chagrin, the firm overdubbed keyboardist Lucky Peterson and chopped out some masterly guitar work when it reissued the set as Lost in the Blues in 1991.


Finally, in 1994, the calling of this Chicago blues fable began travelling in the right focussing. Ain't Enough Comin' In, his first studio record album in 16 days, was released on Mercury and complete up topping many vapors critics' year-end lists. Produced spotlessly by John Porter with a skintight lot, Rush roared a coif of nada only covers -- only did them all his way, his hot guitar consistently to the fore.


Once again, a series of personal problems threatened to end Rush's long-overdue return to national jut ahead it got turned the base. But he's been in super form in late days, fronting a tight band that's solely sympathetic to the guitarist's sizzling approach shot. Rush sign-language with the House of Blues' fledgeling record pronounce, instantaneously granting that ship's company a large dose of believability and place setting himself up for some other career push. It still may not be too previous for Otis Rush to assume his rightful throne as Chicago's blues billie Jean Moffitt King.

Earl Zinger

   
Artist: Earl Zinger

   Genre(s): 
Other
   

---

Discography:


   
 Speaker Stack Commandments

   Year: 2004   
Tracks: 19

---

Electronica creative person Earl Zinger is in reality none other than Rob Gallagher, wHO erstwhile lED the Talkin' Loud label's acid wind band Galliano. Zinger owns a well-crafted and telling resumé. Unfortunately, it is highly fabricated. It boasts of his associations with Jack Kerouac, Allen Ginsberg, William S. Burroughs, and other luminaries, while touting his influence over such musical artists as Bob Marley and Bob Dylan. Couch Your Phazers on Stun and Throw Your Health Food Skyward, issued by K/7 in 2002, marked the fabricated Zinger's debut. Gallagher, in his pretext as Zinger, clearly has a sense of humour, which shows in everything from Zinger's songs to the interviews he refuses to conduct only which ar disposed through a third base party world Health Organization supposedly knows him.